- Global Pharma News & Resources

Bone Growth Stimulators Market to Reach $1.87 Bn, Globally, by 2026 at 5.2% CAGR

Pune, Maharashtra, India, February 24 2021 (Wiredrelease) Allied Analytics –:According to the report, the global bone growth stimulators market size accounted for $1.24 billion in 2018, and is expected to reach $1.87 billion by 2026, growing at a CAGR of 5.2% during the forecast period.

Chief reasons for market fluctuations Rise in demand for non-invasive and safer surgical treatments, increase in number of patients demanding bone growth stimulators, and surge in government expenditure on healthcare drive the growth of the global bone growth stimulators market. However, stringent approval process hampers the growth of the market. On the contrary, untapped potential in emerging markets is expected to create lucrative opportunities in the near future.

Request Sample Report at:

Bone growth stimulation devices segment dominated the market

The bone growth stimulation devices segment held the largest share in 2018, accounting for more than half of the global bone growth stimulators market, as it is used to promote bone healing in difficult to fusions or heal fractures by applying ultrasonic or electrical current to the fusion/fracture site. However, the platelet-rich plasma segment is projected to portray the fastest CAGR of 7.0% during the forecast period, as it helps stimulate bone growth.

Hospitals and clinics segment to manifest the fastest CAGR through 2026

The hospitals & clinics segment is expected to register the fastest CAGR of 5.6% during the forecast period. Moreover, the segment held the lion’s share in 2018, contributing to more than half of the global bone growth stimulators market. This is owing to greater awareness in hospital staff toward bone growth stimulator products, availability of different treatment options, palliative care, and higher affordability. The report also includes an analysis of other segments such as home care and others.

North America held the largest share

The market across North America held the largest share in 2018, accounting for more than half of the market, owing to development of technological advanced bone growth stimulators products, increase in prevalence of spinal cord impairments, and rise in non-government & government initiatives to promote healthcare. However, the global bone growth stimulators market across Asia-Pacific is expected to register the highest CAGR of 7.0% during the forecast period.

For Purchase Enquiry at:

Major market players

Arthrex, Inc.Colfax Corporation (DJO Global, Inc)Essex Woodlands Healthcare Partners (Bioventus LLC)Johnson & Johnson (Depuy Synthes)Isto BiologicsOrthofix Medical Inc.Medtronic PlcTerumo CorporationStryker CorporationZimmer Biomet Holdings, Inc.

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 24-Feb-2021